SEARCH

SEARCH BY CITATION

References

  • Alberti KG, Zimmel PZ. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539553.
  • Arner P. (1995) Differences in lipolysis between human subcutaneous and omental adipose tissue. Ann Med 27:435438.
  • Arslanian S. (2002) Type diabetes in children: clinical aspects and risk factors. Horm Res 57(Suppl. 1):1928.
  • Biton V, Levisohn P, Hoyler S, Vuong A, Hammer AE. (2003) Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. J Child Neurol 18:133139.
  • Browing JD, Horton JD. (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147152.
  • Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP. (2002) Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:27962803.
  • Cacciari E, Milani S, Balsamo A, Dammacco F, De Luca F, Chiarelli F, Pasquino AM, Tonni G, Vanelli M. (2002) Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr 56:171180.
  • Canete R, Gil-Campos M, Aguilera CM, Gil A. (2007) Development of insulin resistance and its relation to diet in the obese child. Eur J Nutr 46:181187.
  • Caprio S. (2002) Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 15(Suppl. 1):483487.
  • Chiarelli F, Marcovecchio ML. (2008) Insulin resistance and obesity in childhood. Eur J Endocrinol 159(Suppl. 1):6774.
  • Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157:821827.
  • Covanis A, Gupta AK, Jeavons PM. (1982) Sodium valproate: monotherapy and polytherapy. Epilepsia 23:693720.
  • Cruz ML, Weigensberg MJ, Huang TT-K, Ball Geoff, Shaibi GQ, Goran Michael I. (2003) The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89(1):108113.
  • Csàbi G, Tòròk K, Jeges S, Molnàr D. (2000) Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 159:9194.
  • Egger J, Brett EM. (1981) Effects of sodium valproate in 100 children with special reference to weight. BMJ 283:577580.
  • Fariello RG, Varasi M, Smith MC. (1995) Valproic acid: mechanism of action. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs. 4th ed. Raven Press, New York, pp. 581604.
  • Foreman JR, Karlin JB, Eldestein C, Juhn DJ, Rubestein AH, Scanu AM. (1997) Fractionation of human serum lipoproteins by single-spin gradient ultracentrifugation: quantification of apolipoproteins B and A-1 and lipid component. J Lipid Res 18:5457.
  • Goran MI, Gower BA. (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50:24442450.
  • Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Mauer KR, Johnson CL. (1998) Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879890.
  • Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:13831388.
  • Isojarvi JI, Rattya J, Myllyla VV, Knip M, Koivunen R, Pakarinen AJ, Tekav A, Tapanainen JS. (1998) Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 43:446451.
  • Kohen-Avramoglu R, Theriault A, Adeli K. (2003) Emergence o the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 36:413420.
  • Levitt NS, Lambert EV. (2002) The foetal origins of the metabolic syndrome- a South African perspective. Cardiovasc J S Afr 13:179180.
  • Lewis GF, Steiner G. (1996) Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 19:390393.
  • Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:19881992.
  • Losher W. (1981) Valproate induced changes in GABA metabolism at the subcellular level. Biochem Pharmacol 30:13641366.
  • Marshall WA, Tanner JM. (1969) Variations in the pattern of pubertal changes in girls. Arch Dis Child 49:291303.
  • Marshall WA, Tanner JM. (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:1323.
  • Meckling KA, O’Sullivan C, Saari D. (2004) Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J Clin Endocrinol Metab 89:27172723.
  • National Institutes of Health. (2001) The third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 2001; 01-3670. National Institutes of Health, Bethesda, MD.
  • Novak GP, Maytal J, Alshansky A, Eviatar L, Sy-Kho R, Siddique Q. (1999) Risk of excessive weight gain in epileptic children treated with valproate. J Child Neurol 14:490495.
  • Ozanne Se, Hales CN. (2002) Early programmino of glucose-insulin metabolism. Trends Endocrinol Metab 13:368373.
  • Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12:136141.
  • Pykalisto OJ, Smith PH, Brunzell JD. (1975) Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal and diet-induced activity. J Clin Invest 56:11081117.
  • Pylvanen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojarvi JI. (2002) Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43:514517.
  • Pylvanen V, Pakarinen A, Knip M, Isojarvi JI. (2006a) Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 8:643648.
  • Pylvanen V, Pakarinen A, Knip M, Isojarvi JIT. (2006b) Characterization of insulin secretion in valproate-treated patients with epilepsy. Epilepsia 47:14601464.
  • Reaven GM. Banting Lecture 1988. (1988) Role of insulin resistance in human disease. Diabetes 37:15951607.
  • Sen Y, Kandemir N, Alikasifoglu A, Gonc N, Ozon A. (2008) Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167:11831189.
  • Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802810.
  • Steinberger J, Daniels SR. (2003) Obesity, insulin resistance, diabetes and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107:14481453.
  • Tan H, Orbak Z, Kantarci M, Kocak N, Karaka L. (2005) Valproate-induced insulin resistance in prepubertal girls with epilepsy. J Pediatr Endocrinol Metab 18:985989.
  • Verrotti A, Chiarelli F, Tumini S, Morgese G. (1989) Seasonal variations of glycosylated haemoglobin in diabetic children. Eur J Pediatr 149:146147.
  • Verrotti A, Basciani F, Morresi S, De Martino M, Morgese G, Chiarelli F. (1999) Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 53:230232.
  • Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F. (2002) Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol 17:256258.
  • Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F. (2008) Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 78:171177.
  • Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. (2005) Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 90:1014.
  • Virkamaki A, Ueki K, Kahn CR. (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:153160.
  • Weiss R, Kaufman FR. (2008) Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 31(Suppl. 2):865875.
  • Wirrell EC. (2003) Valproic acid-associated weight gain in older children and teens with epilepsy. Pediatr Neurol 28:126129.
  • Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T. (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37:193220.